Vitamin D evidence guide
Vitamin D: Benefits, Dosage, D3 vs D2 and Safety
Vitamin D is essential, and preventing or correcting genuine deficiency protects normal bone mineralization.
But in generally healthy adults who already meet their needs, routine supplemental vitamin D has not prevented fractures, falls, cancer, cardiovascular disease, respiratory infections or depression.1,2,3,14,15,16,27,40
Research and writing
LongevityMate Editorial Team
Editorial oversight
Lukas Dvorsky, FounderClinical review
Not yet assigned or claimed
Popular claims, verified
What supplement influencers are saying
These claims are included because people encounter them. Follower count, a podcast opinion and a personal routine are not scientific proof.
What is claimed
Evidence check
Exaggerated target; partly supported safety boundary. The 2024 Endocrine Society found no trial-defined universal target, and 4,000 IU is the US adult upper limit—not a routine target or a guarantee of safety. Individual response is too variable for a fixed IU-to-ng/mL rule.
What is claimed
Evidence check
Supported on correcting deficiency; uncertain on the target. Around 50 ng/mL is not an outcome-validated universal goal and is where NIH/FNB begins flagging possible adverse associations.
What is claimed
Evidence check
Exaggerated and underspecified. It bundles unrelated outcomes without dose, baseline status or population in a commercial segment. VITAL found no cardiovascular prevention, VITAL-DEP found no depression prevention, and the 2026 testosterone synthesis found no reproducible androgen effect.
What is claimed
Evidence check
Contradicted as blanket dosing and overstated on prevalence and outcomes. 5,000 IU exceeds the US adult upper limit; low food intake is not the same as biochemical deficiency. Cancer prevention was null, autoimmune follow-up was not durable, and respiratory evidence is narrowly null.
What is claimed
Evidence check
Contradicted target and unsupported fixed ratio. No guideline or outcome trial establishes 60–80 ng/mL, NIH advises caution above 50 ng/mL, and no human outcome evidence validates this D3:K2:magnesium formula. Routine cancer, respiratory and COVID prevention are not supported.
What is claimed
Evidence check
Misleading. Magnesium participates in vitamin D metabolism, but that does not create a universal pill requirement. One 2026 MK-7-only trial in symptomatic coronary disease modestly slowed coronary-calcium progression, but it did not test a D3 + K2 ratio or clinical events; the completed D3 + K2 trial did not show a significant overall calcification benefit.